Christopher H. Evans

Christopher H. Evans, Ph.D., is a Professor at Mayo Clinic College of Medicine and Science, with primary appointments in the Department of Physical Medicine & Rehabilitation and joint appointments in the Department of Orthopedic Surgery and Department of Molecular Medicine at Mayo Clinic, Rochester, Minnesota. He holds the distinguished title of John and Posy Krehbiel Professor of Orthopedics and serves as Director of the Rehabilitation Medicine Research Center and Principal Investigator of the Musculoskeletal Gene Therapy Research Laboratory.

• John and Posy Krehbiel Professor of Orthopedics (2019)
• President, Orthopaedic Research Society (2004–2005)
• Marshall R. Urist, MD Award (2009)
• Arthur Steindler, MD Award (2010)
• Honorary Fellow, Swansea University (2009)

Dr. Evans’ research leverages gene therapy to develop novel treatments for osteoarthritis and musculoskeletal tissue regeneration. His work spans from basic molecular biology to clinical translation, with a focus on intra-articular gene delivery, bone healing, and cartilage repair. He investigates how inflammatory mediators like IL-1β affect stem cell differentiation and tissue regeneration, aiming to modulate these pathways for therapeutic benefit.

The recent publication trends highlight a strong focus on gene therapy for arthritis, particularly using IL-1Ra and BMP-2, as well as innovative approaches like chemically modified RNA and mechanical modulation for bone healing. His studies span preclinical models to human clinical trials, demonstrating a robust translational pipeline. Key themes include chondrocyte senescence, matrix stiffness, epigenetic regulation, and dual-gene delivery systems.

Dr. Evans has secured significant research funding, including grants from the National Institute of Arthritis and Musculoskeletal and Skin Diseases and the Congressionally Directed Medical Research Programs. His laboratory actively mentors postdoctoral fellows and collaborates on multidisciplinary projects aimed at improving outcomes in orthopedics and rehabilitation medicine.

His lab, the Musculoskeletal Gene Therapy Research Laboratory, is at the forefront of developing single-operation, gene-based therapies for osteoarthritis and non-healing fractures, with the goal of reducing disability and healthcare costs. The lab’s work integrates molecular biology, biomechanics, and clinical research to advance regenerative orthobiologics.